Imagine we are playing monopoly. When it is my turn I roll the die five times in a row then choose the roll I prefer, the one which places my piece on a winning square. Wouldn’t you tell me I cannot do that, accuse me of cheating and walk off? It stands to reason that we should not tolerate the equivalent, the changing of endpoints to gain better results, in clinical trials.

Are ‘developed’ and ‘developing’ countries really that different nowadays?

Professor Hans Rosling, a professor of global health at Sweden’s Karolinska Institutet, explores the differences between countries and gives a fantastic demonstration of the capabilities of global health statistics. A very lively video that should interest everyone.

Definitions of medical statistics and biostatistics.